Gritstone bio
GRTS
$0.75
Share price
4.76%
Change (1 day)
-69.63%
Change (1 year)
Categories
Revenue for Gritstone bio (GRTS)
Revenue in 2023 (TTM): $1.33 M
According to Gritstone bio's latest financial reports the company's current revenue (TTM
) is $0.83 M.
In 2022 the company made a revenue of $9.26 M a decrease over the years 2021 revenue that were of $46.71 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Gritstone bio from 2018 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $1.33 M | -85.63% |
| 2022 | $9.26 M | -80.16% |
| 2021 | $46.71 M | 1099.72% |
| 2020 | $3.89 M | -10.79% |
| 2019 | $4.36 M | 267.73% |
| 2018 | $1.18 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |